Extended resection for potentially operable patients with stage III non-small cell lung cancer after induction treatment.

Publikation

Extended resection for potentially operable patients with stage III non-small cell lung cancer after induction treatment.

Wissenschaftlicher Artikel/Review - 18.04.2022

Furrer Katarzyna, Weder Walter, Eboulet Eric Innocents, Betticher Daniel, Pless Miklos, Stupp Roger, Krueger Thorsten, Perentes Jean Yannis, Schmid Ralph A, Lardinois Didier, Furrer Markus, Früh Martin, Peters Solange, Curioni-Fontecedro Alessandra, Stahel Rolf A, Rothschild Sacha I, Hayoz Stefanie, Opitz Isabelle

Zitation

Furrer K, Weder W, Eboulet E, Betticher D, Pless M, Stupp R, Krueger T, Perentes J, Schmid R, Lardinois D, Furrer M, Früh M, Peters S, Curioni-Fontecedro A, Stahel R, Rothschild S, Hayoz S, Opitz I. Extended resection for potentially operable patients with stage III non-small cell lung cancer after induction treatment. J Thorac Cardiovasc Surg 2022; 164:1587-1602.e5.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

J Thorac Cardiovasc Surg 2022; 164

Veröffentlichungsdatum

18.04.2022

eISSN (Online)

1097-685X

Seiten

1587-1602.e5

Kurzbeschreibung/Zielsetzung

Surgical treatment of locally advanced non-small cell lung cancer including single or multilevel N2 remains a matter of debate. Several trials demonstrate that selected patients benefit from surgery if R0 resection is achieved. We aimed to assess resectability and outcome of patients with locally advanced clinical T3/T4 (American Joint Committee on Cancer 8 edition) tumors after induction treatment followed by surgery in a pooled analysis of 3 prospective multicenter trials.